領航醫藥生物科技：中期報告2023-2024.pdf

1、INTERIM REPORT2023/24中期報告(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)Contents目錄2Corporat

2、e Information公司資料4Chairmans Statement主席報告6Management Discussion and Analysis管理層討論及分析17Other Information Provided in Accordance with the Listing Rules根據上市規則披露之其他資料23Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income簡明綜合損益及其他全面收益表26Condensed Consolidated Statement of Fin

3、ancial Position簡明綜合財務狀況表29Condensed Consolidated Statement of Changes in Equity簡明綜合權益變動表31Condensed Consolidated Statement of Cash Flows簡明綜合現金流量表32Notes to the Condensed Consolidated Financial Statements簡明綜合財務報表附註Corporate Information公司資料2INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED 2023/24 Interim Rep

4、ortBOARD OF DIRECTORSExecutive DirectorsGao Yuan XingTang RongCheng Tak YiuNon-executive DirectorsJiang Nian(Chairman)Xiao YanWu YanminIndependent non-executive DirectorsChen WeijunWang RongliangChen JinzhongAudit CommitteeChen Weijun(Chairman)Wang RongliangChen JinzhongRemuneration CommitteeWang Ro

5、ngliang(Chairman)Jiang NianChen JinzhongNomination CommitteeJiang Nian(Chairman)Wang RongliangChen JinzhongHONORARY CHAIRMANMao YuminCOMPANY SECRETARYPoon Hon YinREGISTERED OFFICEClarendon House2 Church StreetHamilton HM 11,Bermuda董事會執行董事高源興唐榕鄭德耀非執行董事蔣年（主席）肖焱鄔燕敏獨立非執行董事陳偉君王榮樑陳金中審核委員會陳偉君（主席）王榮樑陳金中薪酬委員

6、會王榮樑（主席）蔣年陳金中提名委員會蔣年（主席）王榮樑陳金中名譽主席毛裕民公司秘書潘漢彥註冊辦事處Clarendon House2 Church StreetHamilton HM 11,BermudaCorporate Information公司資料32023/24年中期報告 領航醫藥及生物科技有限公司PRINCIPAL PLACE OF BUSINESS IN HONG KONGUnit 2002,20th floorOn Hong Commercial Building145 Hennessy RoadWan Chai,Hong KongPRINCIPAL SHARE REGISTRAR